Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer
©2016 American Association for Cancer Research..
Cancer cells use stress response pathways to sustain their pathogenic behavior. In breast cancer, stress response-associated phenotypes are mediated by the breast tumor kinase, Brk (PTK6), via the hypoxia-inducible factors HIF-1α and HIF-2α. Given that glucocorticoid receptor (GR) is highly expressed in triple-negative breast cancer (TNBC), we investigated cross-talk between stress hormone-driven GR signaling and HIF-regulated physiologic stress. Primary TNBC tumor explants or cell lines treated with the GR ligand dexamethasone exhibited robust induction of Brk mRNA and protein that was HIF1/2-dependent. HIF and GR coassembled on the BRK promoter in response to either hypoxia or dexamethasone, indicating that Brk is a direct GR/HIF target. Notably, HIF-2α, not HIF-1α, expression was induced by GR signaling, and the important steroid receptor coactivator PELP1 was also found to be induced in a HIF-dependent manner. Mechanistic investigations showed how PELP1 interacted with GR to activate Brk expression and demonstrated that physiologic cell stress, including hypoxia, promoted phosphorylation of GR serine 134, initiating a feed-forward signaling loop that contributed significantly to Brk upregulation. Collectively, our findings linked cellular stress (HIF) and stress hormone (cortisol) signaling in TNBC, identifying the phospho-GR/HIF/PELP1 complex as a potential therapeutic target to limit Brk-driven progression and metastasis in TNBC patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:76 |
---|---|
Enthalten in: |
Cancer research - 76(2016), 6 vom: 15. März, Seite 1653-63 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Regan Anderson, Tarah M [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 25.07.2016 Date Revised 02.12.2018 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1158/0008-5472.CAN-15-2510 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM256976848 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM256976848 | ||
003 | DE-627 | ||
005 | 20231224181822.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1158/0008-5472.CAN-15-2510 |2 doi | |
028 | 5 | 2 | |a pubmed24n0856.xml |
035 | |a (DE-627)NLM256976848 | ||
035 | |a (NLM)26825173 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Regan Anderson, Tarah M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.07.2016 | ||
500 | |a Date Revised 02.12.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a ©2016 American Association for Cancer Research. | ||
520 | |a Cancer cells use stress response pathways to sustain their pathogenic behavior. In breast cancer, stress response-associated phenotypes are mediated by the breast tumor kinase, Brk (PTK6), via the hypoxia-inducible factors HIF-1α and HIF-2α. Given that glucocorticoid receptor (GR) is highly expressed in triple-negative breast cancer (TNBC), we investigated cross-talk between stress hormone-driven GR signaling and HIF-regulated physiologic stress. Primary TNBC tumor explants or cell lines treated with the GR ligand dexamethasone exhibited robust induction of Brk mRNA and protein that was HIF1/2-dependent. HIF and GR coassembled on the BRK promoter in response to either hypoxia or dexamethasone, indicating that Brk is a direct GR/HIF target. Notably, HIF-2α, not HIF-1α, expression was induced by GR signaling, and the important steroid receptor coactivator PELP1 was also found to be induced in a HIF-dependent manner. Mechanistic investigations showed how PELP1 interacted with GR to activate Brk expression and demonstrated that physiologic cell stress, including hypoxia, promoted phosphorylation of GR serine 134, initiating a feed-forward signaling loop that contributed significantly to Brk upregulation. Collectively, our findings linked cellular stress (HIF) and stress hormone (cortisol) signaling in TNBC, identifying the phospho-GR/HIF/PELP1 complex as a potential therapeutic target to limit Brk-driven progression and metastasis in TNBC patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 7 | |a Basic Helix-Loop-Helix Transcription Factors |2 NLM | |
650 | 7 | |a Co-Repressor Proteins |2 NLM | |
650 | 7 | |a Hypoxia-Inducible Factor 1, alpha Subunit |2 NLM | |
650 | 7 | |a Neoplasm Proteins |2 NLM | |
650 | 7 | |a PELP1 protein, human |2 NLM | |
650 | 7 | |a RNA, Messenger |2 NLM | |
650 | 7 | |a Receptors, Glucocorticoid |2 NLM | |
650 | 7 | |a Transcription Factors |2 NLM | |
650 | 7 | |a endothelial PAS domain-containing protein 1 |2 NLM | |
650 | 7 | |a 1B37H0967P |2 NLM | |
650 | 7 | |a Dexamethasone |2 NLM | |
650 | 7 | |a 7S5I7G3JQL |2 NLM | |
650 | 7 | |a Protein-Tyrosine Kinases |2 NLM | |
650 | 7 | |a EC 2.7.10.1 |2 NLM | |
650 | 7 | |a PTK6 protein, human |2 NLM | |
650 | 7 | |a EC 2.7.10.2 |2 NLM | |
700 | 1 | |a Ma, Shi Hong |e verfasserin |4 aut | |
700 | 1 | |a Raj, Ganesh V |e verfasserin |4 aut | |
700 | 1 | |a Cidlowski, John A |e verfasserin |4 aut | |
700 | 1 | |a Helle, Taylor M |e verfasserin |4 aut | |
700 | 1 | |a Knutson, Todd P |e verfasserin |4 aut | |
700 | 1 | |a Krutilina, Raisa I |e verfasserin |4 aut | |
700 | 1 | |a Seagroves, Tiffany N |e verfasserin |4 aut | |
700 | 1 | |a Lange, Carol A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancer research |d 1945 |g 76(2016), 6 vom: 15. März, Seite 1653-63 |w (DE-627)NLM000001740 |x 1538-7445 |7 nnns |
773 | 1 | 8 | |g volume:76 |g year:2016 |g number:6 |g day:15 |g month:03 |g pages:1653-63 |
856 | 4 | 0 | |u http://dx.doi.org/10.1158/0008-5472.CAN-15-2510 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 76 |j 2016 |e 6 |b 15 |c 03 |h 1653-63 |